General Information
Revision date
2016-09-19
Product name
Dutasteride Capsules
CAS No.
164656-23-9
1.2.1 Relevant identified uses
Indicated for the treatment of symptomatic BPH in men with an enlarged prostate
1.2.2. Uses advised against
For use in men only
Icons in SDS
Company Information
company name
West-Ward Pharmaceuticals Corporation
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Reproductive toxicity Category 1B
Signal word
Danger
Hazard statements
May damage fertility or the unborn child. This is a pharmaceutical product designed to be prescribed by a licensed health care professional. Should any person while using this product observe any adverse health effects, they should seek medical treatment.
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves/protective clothing/eye protection/face protection. Observe good industrial hygiene practices.
Response
If exposed or concerned: Get medical advice/attention. Wash hands after handling.
Storage
Store locked up. Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Incineration of waste at an approved USEPA incinerator is recommended. Hazard(s) not otherwise None known. classified (HNOC)
Additional information
None.
2.1 Classification of the substance or mixture
Not classified. Health hazards Reproductive toxicity Category 1B OSHA defined hazards Not classified.
